Evidence map›Paper›PMID 24713664›Full record

ArticleEuropean journal of human genetics : EJHG2014

Human active X-specific DNA methylation events showing stability across time and tissues.

Jihoon Eric Joo, Boris Novakovic, Mark Cruickshank, Lex W Doyle, Jeffrey M Craig, Richard Saffery

Abstract readTwin Study
In one paragraph

Article in European journal of human genetics : EJHG, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. DNA methylation impact on Fabry disease.Clinical epigenetics · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Allele-specific non-CG DNA methylation marks domains of active chromatin in female mouse brain.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jihoon Eric JooCancer and Disease Epigenetics, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Boris Novakovic1] Cancer and Disease Epigenetics, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia [2] Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
Mark CruickshankLeukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Western Australia, Australia.
Lex W Doyle1] Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia [2] Neonatal Services, Royal Women's Hospital, Parkville, Victoria, Australia [3] Department of Obstetrics and Gynaecology, University of Melbourne, Royal Women's Hospital, Parkville, Victoria, Australia.
Jeffrey M Craig1] Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia [2] Early Life Epigenetics, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Richard Saffery1] Cancer and Disease Epigenetics, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia [2] Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The phenomenon of X chromosome inactivation in female mammals is well characterised and remains the archetypal example of dosage compensation via monoallelic expression. The temporal series of events that culminates in inactive X-specific gene silencing by DNA methylation has revealed a 'patchwork' of gene inactivation along the chromosome, with approximately 15% of genes escaping. Such genes are therefore potentially subject to sex-specific imbalance between males and females. Aside from XIST, the non-coding RNA on the X chromosome destined to be inactivated, very little is known about the extent of loci that may be selectively silenced on the active X chromosome (Xa). Using longitudinal array-based DNA methylation profiling of two human tissues, we have identified specific and widespread active X-specific DNA methylation showing stability over time and across tissues of disparate origin. Our panel of X-chromosome loci subject to methylation on Xa reflects a potentially novel mechanism for controlling female-specific X inactivation and sex-specific dimorphisms in humans. Further work is needed to investigate these phenomena.

Indexed as

DNA MethylationChromosomes, Human, XDatabases, GeneticDosage Compensation, GeneticFemaleGene Expression RegulationGene SilencingGenetic LociHumansMaleRNA, UntranslatedX Chromosome InactivationRNA, Untranslated

Identifiers

PMID24713664
PMCPMC4231404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.